The Fanconi Syndrome

Genetic Diseases of the Kidney

Volumn , Issue , 2009, Pages 171-197

  Moe, Orson W ^a   Seldin, Donald W ^a   Baum, Michel ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953663733     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-449851-8.00010-3     Document Type: Chapter

References (281)

1. Abderhalden E Familiäre cystindiathese. Hoppe-Seylers Zeitschrift für physiologische Chemie. Strassburg 1903, 38:557-561.
2. Acker KJ, Roels H, Beelaerts W, Pasternack A, Valcke R The histologic lesions of the kidney in the oculo-cerebro-renal syndrome of Lowe. Nephron 1967, 4:193-214.
3. Al Bander H, Etheredge SB, Paukert T, Humphreys MH, Morris RC Phosphate loading attenuates renal tubular dysfunction induced by maleic acid in the dog. Am. J. Physiol. 1985, 248:F513-F521.
4. Al Bander HA, Mock DM, Etheredge SB, Paukert TT, Humphreys MH, Morris RC Coordinately increased lysozymuria and lysosomal enzymuria induced by maleic acid. Kidney Int. 1986, 30:804-812.
5. Ali M, Rellos P, Cox TM Hereditary fructose intolerance. J. Med. Genet. 1988, 35:353-365.
6. Angielski S, Rogulski J Effect of maleic acid on the kidney. I. Oxidation of Krebs cycle intermediates by various tissues of maleate-intoxicated rats. Acta Biochim. Pol. 1962, 9:357-365.
7. Aronson PS, Giebisch G Mechanisms of chloride transport in the proximal tubule. Am. J. Physiol. 1997, 273:F179-F192.
8. Asatoor AM, Milne MD, Walshe JM The effect of chelation therapy on the amino aciduria and peptiduria of Wilson's disease. J. R. Coll. Physicians Lond. 1983, 17:122-125.
9. Aucouturier P, Bauwens M, Khamlichi AA, et al. Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome. J. Immunol. 1993, 150:3561-3568.
10. Auricchio S, Frischknecht W Shmerlingd. Primary tubulopathies. III. A case of oculo-cerebro-renal syndrome (Lowe syndrome). Helv. Paediatr. Acta 1961, 16:647-655.
11. Austin JH Metachromatic form of diffuse cerebral sclerosis. III. Significance of sulfatide and other lipid abnormalities in white matter and kidney. Neurology 1960, 10:470-483.
12. Bajaj G, Baum M Proximal tubule dysfunction in cystine-loaded tubules: effect of phosphate and metabolic substrates. Am. J. Physiol. 1996, 271:F717-F722.
13. Bank N, Aynedjian HS, Mutz BF Microperfusion study of proximal tubule bicarbonate transport in maleic acid-induced renal tubular acidosis. Am. J. Physiol. 1986, 250:F476-F482.
14. Baran DT, Marcy TW Evidence for a defect in vitamin D metabolism in a patient with incomplete Fanconi syndrome. J. Clin. Endocrinol. Metab. 1984, 59:998-1001.
15. Barbier O, Jacquillet G, Tauc M, Cougnon M, Poujeol P Effect of heavy metals on, and handling by, the kidney. Nephron Physiol. 2005, 99:105-110.
16. Baum M Developmental changes in rabbit juxtamedullary proximal convoluted tubule acidification. Pediatr. Res. 1992, 31:411-414.
17. Baum M The Fanconi syndrome of cystinosis: insights into the pathophysiology. Pediatr. Nephrol. 1998, 12:492-497.
18. Baum M, Berry CA Evidence for neutral transcellular NaCl transport and neutral basolateral chloride exit in the rabbit convoluted tubule. J. Clin. Invest. 1984, 74:205-211.
19. Bergeron M, Dubord L, Hausser C, Schwab C Membrane permeability as a cause of transport defects in experimental Fanconi syndrome. A new hypothesis. J. Clin. Invest. 1976, 57:1181-1189.
20. Bergeron M, Gougoux A, Vinay P The Metabolic and Molecular Basis of Inherited Disease 1995, 2691-3716. McGraw-Hill, New York. M. Bergeron, A. Gougoux, P. Vinay (Eds.).
21. Bergeron M, Mayers P, Brown D Specific effect of maleate on an apical membrane glycoprotein (gp330) in proximal tubule of rat kidneys. Am. J. Physiol. 1996, 271:F908-F916.
22. Berio A, Piazzi A Kearns-Sayre syndrome associated with de Toni-Debre-Fanconi syndrome due to cytochrome-c-oxidase (COX) deficiency. Panminerva Med. 2001, 43:211-214.
23. Berliner RW, Kennedy TJ, Hilton JG Effect of maleic acid on renal function. Proc. Soc. Exp. Biol. Med. 1950, 75:791-794.
24. Berry GT, Baker L, Kaplan FS, Witzleben CL Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome. Pediatr. Nephrol. 1995, 9:287-291.
25. Betend B, David L, Vincent M, Hermier M, Francois R Successful indomethacin treatment of two paediatric patients with severe tubulopathies. A boy with an unusual hypercalciuria and a girl with cystinosis. Helv. Paediatr. Acta 1979, 34:339-344.
26. Bingham C, Ellard S, Nicholls AJ, et al. The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria. Diabetes 2001, 50:2047-2052.
27. Blumenthal SS, Lewand DL, Buday MA, Kleinman JG, Krezoski SK, Petering DH Cadmium inhibits glucose uptake in primary cultures of mouse cortical tubule cells. Am. J. Physiol. 1990, 258:F1625-F1633.
28. Bonnardeaux A, Bichet DG Inherited disorders of the renal tubule. The Kidney 1999, 1656-1698. W.B. Saunders, Philadelphia. B.M. Brenner (Ed.).
29. Bonsib SM, Horvath F Multinucleated podocytes in a child with nephrotic syndrome and Fanconi's syndrome: A unique clue to the diagnosis. Am. J. Kidney Dis. 1999, 34:966-971.
30. Bovee KC, Joyce T, Reynolds R, Segal S The fanconi syndrome in Basenji dogs: a new model for renal transport defects. Science 1978, 201:1129-1131.
31. Brazy PC, Gullans SR, Mandel LJ, Dennis VW Metabolic requirement for inorganic phosphate by the rabbit proximal tubule. J. Clin. Invest. 1982, 70:53-62.
32. Breitschwerdt EB, Ochoa R, Waltman C Multiple endocrine abnormalities in Basenji dogs with renal tubular dysfunction. J. Am. Vet. Med. Assoc. 1983, 182:1348-1353.
33. Brewer ED, Tsai HC, Szeto KS, Morris RC Maleic acid-induced impaired conversion of 25(OH)D3 to 1,25(OH)2D3: implications for Fanconi's syndrome. Kidney Int. 1977, 12:244-252.
34. Bridoux F, Sirac C, Hugue V, et al. Fanconi's syndrome induced by a monoclonal Vkappa3 light chain in Waldenstrom's macroglobulinemia. Am. J. Kidney Dis. 2005, 45:749-757.
35. Brown D, Stow JL Protein trafficking and polarity in kidney epithelium: from cell biology to physiology. Physiol. Rev. 1996, 76:245-297.
36. Cachat F, Guignard JP The kidney in children under chemotherapy. Rev. Med. Suisse Romande 1996, 116:985-993.
37. Cachat F, Nenadov-Beck M, Guignard JP Occurrence of an acute Fanconi syndrome following cisplatin chemotherapy. Med. Pediatr. Oncol. 1998, 31:40-41.
38. Campos Y, Garcia-Silva T, Barrionuevo CR, Cabello A, Muley R, Arenas J Mitochondrial DNA deletion in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes (MELAS) and Fanconi's syndrome. Pediatr. Neurol. 1995, 13:69-72.
39. Castano E, Marzabal P, Casado FJ, Felipe A, Pastor-Anglada M Na+,K(+)-ATPase expression in maleic-acid-induced Fanconi syndrome in rats. Clin. Sci. (Lond) 1997, 92:247-253.
40. Charnas LR, Bernardini I, Rader D, Hoeg JM, Gahl WA Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N. Engl. J. Med. 1991, 324:1318-1325.
41. Chen YT Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment. Pediatr. Nephrol. 1991, 5:71-76.
42. Chen YT, Coleman RA, Scheinman JI, Kolbeck PC, Sidbury JB Renal disease in type I glycogen storage disease. N. Engl. J. Med. 1998, 318:7-11.
43. Cherqui S, Sevin C, Hamard G, et al. Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. Mol. Cell Biol. 2002, 22:7622-7632.
44. Chesney RW, Rosen JF, Hamstra AJ, Deluca HF Serum 1,25 dihydroxyvitamin D levels in normal children and in vitamin D disorders. Am. J. Dis. Child. 1980, 134:135-139.
45. Chisholm CA, Vavelidis F, Lovell MA, et al. Prenatal diagnosis of multiple acyl-CoA dehydrogenase deficiency: association with elevated alpha-fetoprotein and cystic renal changes. Prenat. Diagn. 2001, 21:856-859.
46. Christensen EI, Birn H Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am. J. Physiol. Renal Physiol. 2001, 280:F562-F573.
47. Christensen EI, Devuyst O, Dom G, et al. Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc. Natl Acad. Sci. USA 2003, 100:8472-8477.
48. Christensen EI, Gburek J Protein reabsorption in renal proximal tubule-function and dysfunction in kidney pathophysiology. Pediatr. Nephrol. 2004, 19:714-721.
49. Clark DA, Butler SA, Braren V, Hartmann RC, Jenkins DE The kidneys in paroxysmal nocturnal hemoglobinuria. Blood 1981, 57:83-89.
50. Clarke BL, Wynne AG, Wilson DM, Fitzpatrick LA Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin. Endocrinol. (Oxf) 1995, 43:479-490.
51. Clayton PT, Hyland K, Brand M, Leonard JV Mitochondrial phosphoenolpyruvate carboxykinase deficiency. Eur. J. Pediatr. 1986, 145:46-50.
52. Cleveland WW, Adams WC, Mann JB, Nyhan WL Acquired Fanconi syndrome following degraded tetracyline. J. Pediatr. 1965, 66:333-342.
53. Cochat P, Guibaud P, Baverel G Renal involvement in type I tyrosinemia. Arch. Pediatr. 1994, 1:417-418.
54. Collazo R, Fan L, Zhao H, Wiederkehr M, Moe OW Acute regulation of Na+/H+ exchanger NHE3 by parathyroid hormone via NHE3 phosphorylation and dynamin-dependent endocytosis. J. Biol. Chem. 2000, 275:31601-31608.
55. Colussi G, De Ferrari ME, Surian M, et al. Vitamin D metabolites and osteomalacia in the human Fanconi syndrome. Proc. Eur. Dial. Transplant Assoc. Eur. Ren. Assoc. 1985, 21:756-760.
56. Coor C, Salmon RF, Quigley R, Marver D, Baum M Role of adenosine triphosphate (ATP) and NaK ATPase in the inhibition of proximal tubule transport with intracellular cystine loading. J. Clin. Invest. 1991, 87:955-961.
57. Cori GT, Cori CF Glucose-6-phosphatase of the liver in glycogen storage disease. J. Biol. Chem. 1952, 199:661-667.
58. Crabtree HG Observations on the carbohydrate metabolism of tumors. Biochem. J. 1929, 23:536-545.
59. Cross NC, Tolan DR, Cox TM Catalytic deficiency of human aldolase B in hereditary fructose intolerance caused by a common missense mutation. Cell 1988, 53:881-885.
60. Cunningham J, Bikle DD, Avioli LV Acute, but not chronic, metabolic acidosis disturbs 25-hydroxyvitamin D3 metabolism. Kidney Int. 1984, 25:47-52.
61. Cunningham R, Steplock D, Wang F, et al. Defective parathyroid hormone regulation of NHE3 activity and phosphate adaptation in cultured NHERF-1-/- renal proximal tubule cells. J. Biol. Chem. 2004, 279:37815-37821.
62. Cvoriscec D, Ceovic S, Borso G, Rukavina AS Endemic nephropathy in Croatia. Clin. Chem. Lab. Med. 1998, 36:271-277.
63. Das SK, Ray K Wilson's disease: an update. Nat. Clin. Pract. Neurol. 2006, 2:482-493.
64. Daugaard G, Abildgaard U, Holstein-Rathlou NH, Bruunshuus I, Bucher D, Leyssac PP Renal tubular function in patients treated with high-dose cisplatin. Clin. Pharmacol. Ther. 1988, 44:164-172.
65. De Lorenzo F, Hargreaves J, Kakkar VV Phosphate diabetes in patients with chronic fatigue syndrome. Postgrad. Med. J. 1998, 74:229-232.
66. De Toni G Remarks on the relations between renal rickets (renal dwarfism) and renal diabetes. Acta Paediatr. 1933, 16:479.
67. Debre R Rachitisme tardif coexistant avec une nephrite chronique et une glycosurie. Arch. Med. Enf. 1934, 37:597.
68. Dent CE, Friedman M Hypercaliuric rickets associated with renal tubular damage. Arch. Dis. Child. 1964, 39:240-249.
69. Earle KE, Seneviratne T, Shaker J, Shoback D Fanconi's syndrome in HIV+ adults: report of three cases and literature review. J. Bone Miner. Res. 2004, 19:714-721.
70. Eiam-Ong S, Spohn M, Kurtzman NA, Sabatini S Insights into the biochemical mechanism of maleic acid-induced Fanconi syndrome. Kidney Int. 1995, 48:1542-1548.
71. Elsas LJ, Hayslett JP, Spargo BH, Durant JL, Rosenberg LE Wilson's disease with reversible renal tubular dysfunction. Correlation with proximal tubular ultrastructure. Ann. Intern. Med. 1971, 75:427-433.
72. Elsas LJ, Lai K The molecular biology of galactosemia. Genet. Med. 1998, 1:40-48.
73. Endo F, Sun MS Tyrosinaemia type I and apoptosis of hepatocytes and renal tubular cells. J. Inherit. Metab. Dis. 2002, 25:227-234.
74. Fan L, Wiederkehr MR, Collazo R, et al. Dual mechanisms of regulation on Na/H exchanger NHE-3 by parathyroid hormone in rat kidney. J. Biol. Chem. 1999, 274:11289-11295.
75. Fanconi G Die nicht diabetischen Glykosurien und Hyperglykamien des altern Kindes. Jahrb. Kinderheilk 1931, 133:257.
76. Fanconi G Der fruhinfantile nephrotsch-glykosurische Zwergwuchs mit hypophospahtamischer Rachitis. Jahrb. Kinderheilk 1936, 147:299.
77. Fanconi G, Bickel H Die chronische aminoacidurie (aminosaeurediabetes oder nephrotisch-glukosurisscher zwergwuchs) ber der glykogenose und cystinkrankheit. Helv. Paediatr. Acta 1949, 4:359-396.
78. Finzer KH Lower nephron nephrosis due to concentrated Lysol vaginal douches: a report of two cases. Can. Med. Assoc. J. 1961, 84:549.
79. Fisher SE, Black GC, Lloyd SE, et al. Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candidate for Dent's disease (an X-linked hereditary nephrolithiasis). Hum. Mol. Genet. 1994, 3:2053-2059.
80. Fisher SE, Lloyd SE, Pearce SH, Thakker RV, Craig IW Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis). Genomics 1995, 29:598-606.
81. Foreman JW, Benson L Effect of cystine loading and cystine dimethylester on renal brushborder membrane transport. Biosci. Rep. 1990, 10:455-459.
82. Foreman JW, Benson LL Effect of cystine loading on substrate oxidation by rat renal tubules. Pediatr. Nephrol. 1990, 4:236-239.
83. Foreman JW, Benson LL, Wellons M, et al. Metabolic studies of rat renal tubule cells loaded with cystine: the cystine dimethylester model of cystinosis. J. Am. Soc. Nephrol. 1995, 6:269-272.
84. Foreman JW, Bowring MA, Lee J, States B, Segal S Effect of cystine dimethylester on renal solute handling and isolated renal tubule transport in the rat: a new model of the Fanconi syndrome. Metabolism 1987, 36:1185-1191.
85. Frerman FE, Goodman SI Defects of electron transfer flavoprotein and electron transfer flavoprotein-ubiquinone oxidoreductase: gllutaric acidemia type II. The Metabolic and Molecular Bases of Inherited Disease 2001, 2357-2365. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
86. Friedman A, Chesney R Fanconi's syndrome in renal transplantation. Am. J. Nephrol. 1981, 1:45-47.
87. Gahl WA, Thoene JG, Schneider JA Cystinosis. N. Engl. J. Med. 2002, 347:111-121.
88. Gainza FJ, Minguela JI, Lampreabe I Aminoglycoside-associated Fanconi's syndrome: an underrecognized entity. Nephron 1997, 77:205-211.
89. Garty R, Cooper M, Tabachnik E The Fanconi syndrome associated with hepatic glycogenosis and abnormal metabolism of galactose. J. Pediatr. 1974, 85:821-823.
90. Gekle M Renal tubule albumin transport. Annu. Rev. Physiol. 2005, 67:573-594.
91. Gieselmann V, Franken S, Klein D, et al. Metachromatic leukodystrophy: consequences of sulphatide accumulation. Acta Paediatr. Suppl. 2003, 92:74-79.
92. Gil HW, Yang JO, Lee EY, Hong SY Paraquat-induced Fanconi syndrome. Nephrology (Carlton) 2005, 10:430-432.
93. Gonick H, Indraprasit S, Neustein H, Rosen V Cadmium-induced experimental Fanconi syndrome. Curr. Probl. Clin. Biochem. 1975, 4:111-118.
94. Gonick H, Indraprasit S, Rosen V, Neustein H, Van de Velde R, Raghavan SRV Experimental Fanconi syndrome: III. Effect of cadmium on renal tubular function, the ATP-Na-K-ATPase transport system and renal tubular ultrastructure. Miner. Electrolyte Metab. 1980, 3:21-35.
95. Greco DS Congenital and inherited renal disease of small animals. Vet. Clin. North Am. Small Anim. Pract. 2001, 31:393-399. viii.
96. Grompe M, St Louis M, Demers SI, al Dhalimy M, Leclerc B, Tanguay RM A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I. N. Engl. J. Med. 1994, 331:353-357.
97. Gross JM Fanconi syndrome (adult type) developing secondary to the ingestion of outdated tetracycline. Ann. Intern. Med. 1963, 58:523-528.
98. Guan S, el Dahr S, Dipp S, Batuman V Inhibition of Na-K-ATPase activity and gene expression by a myeloma light chain in proximal tubule cells. J. Investig. Med. 1999, 47:496-501.
99. Gunther R, Silbernagl S, Deetjen P Maleic acid induced aminoaciduria, studied by free flow micropuncture and continuous microperfusion. Pflugers Arch. 1979, 382:109-114.
100. Gunther W, Luchow A, Cluzeaud F, Vandewalle A, Jentsch TJ ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc. Natl Acad. Sci. USA 1998, 95:8075-8080.
101. Gunther W, Piwon N, Jentsch TJ The ClC-5 chloride channel knockout mouse - an animal model for Dent's disease. Pflugers Arch. 2003, 445:456-462.
102. Guntupalli J, Delaney V, Bourke E Studies on the maleic acid-induced Fanconi syndrome in the rat: mechanism of phosphaturia and its mitigation by dietary phosphate restriction. Contrib. Nephrol. 1991, 92:83-92.
103. Haq MR, Kalatzis V, Gubler MC, et al. Immunolocalization of cystinosin, the protein defective in cystinosis. J. Am. Soc. Nephrol. 2002, 13:2046-2051.
104. Haycock GB, Al Dahhan J, Mak RH, Chantler C Effect of indomethacin on clinical progress and renal function in cystinosis. Arch. Dis. Child. 1982, 57:934-939.
105. Herak-Kramberger CM, Brown D, Sabolic I Cadmium inhibits vacuolar H(+)-ATPase and endocytosis in rat kidney cortex. Kidney Int. 1998, 53:1713-1726.
106. Herak-Kramberger CM, Spindler B, Biber J, Murer H, Sabolic I Renal type II Na/Pi-cotransporter is strongly impaired whereas the Na/sulphate-cotransporter and aquaporin 1 are unchanged in cadmium-treated rats. Pflugers Arch. 1996, 432:336-344.
107. Hilpert J, Nykjaer A, Jacobsen C, et al. Megalin antagonizes activation of the parathyroid hormone receptor. J. Biol. Chem. 1999, 274:5620-5625.
108. Hodges RE, Kirkendall WM Renal tubule and Wilson's disease. Ann. Intern. Med. 1972, 76:835-836.
109. Hommes FA, Bendien K, Elema JD, Bremer HJ, Lombeck I Two cases of phosphoenolpyruvate carboxykinase deficiency. Acta Paediatr. Scand. 1976, 65:233-240.
110. Hoopes RR, Raja KM, Koich A, et al. Evidence for genetic heterogeneity in Dent's disease. Kidney Int. 2004, 65:1615-1620.
111. Hoppe B, Neuhaus T, Superti-Furga A, Forster I, Leumann E Hypercalciuria and nephrocalcinosis, a feature of Wilson's disease. Nephron 1993, 65:460-462.
112. Hostutler RA, DiBartola SP, Eaton KA Transient proximal renal tubular acidosis and Fanconi syndrome in a dog. J. Am. Vet. Med. Assoc. 2004, 224:1611-1614.
113. Houston IB, Boichis H, Edelmann CM Fanconi syndrome with renal sodium wasting and metabolic alkalosis. Am. J. Med. 1968, 44:638-646.
114. Hsu BY, McNamara PD, Mahoney SG, et al. Membrane fluidity and sodium transport by renal membranes from dogs with spontaneous idiopathic Fanconi syndrome. Metabolism 1992, 41:253-259.
115. Hsu BY, Wehrli SL, Yandrasitz JR, et al. Renal brush border membrane lipid composition in Basenji dogs with spontaneous idiopathic Fanconi syndrome. Identification of a mutation in the arylsulfatase A gene of a pation with adult-type metachromatic leukodystrophy. Am. J. Hum. Genet. 1991, 48:971-978.
116. Igarashi T, Kawato H, Kamoshita S, Nosaka K, Seiya K, Hayakawa H Acute tubulointerstitial nephritis with uveitis syndrome presenting as multiple tubular dysfunction including Fanconi's syndrome. Pediatr. Nephrol. 1992, 6:547-549.
117. Insogna KL, Bordley DR, Caro JF, Lockwood DH Osteomalacia and weakness from excessive antacid ingestion. JAMA 1980, 244:2544-2546.
118. Jacobs SM, van Beurden DH, Klomp LW, Berger R Kidneys of mice with hereditary tyrosinemia type I are extremely sensitive to cytotoxicity. Pediatr. Res. 2006, 59:365-370.
119. Jamieson PM, Chandler ML Transient renal tubulopathy in a Labrador retriever. J. Small Anim. Pract. 2001, 42:546-549.
120. Kalatzis V, Cherqui S, Antignac C, Gasnier B Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J. 2001, 20:5940-5949.
121. Kellerman PS Exogenous adenosine triphosphate (ATP) preserves proximal tubule microfilament structure and function in vivo in a maleic acid model of ATP depletion. J. Clin. Invest. 1993, 92:1940-1949.
122. Kihara H Genetic heterogeneity in metachromatic leukodystrophy. Am. J. Hum. Genet. 1982, 34:171-181.
123. Kihara H, Fluharty AL, O'Brien JS, Fish CH Metachromatic leukodystrophy caused by a partial cerebroside sulfatase. Clin. Genet. 1982, 21:253-261.
124. Kihara H, Meek WE, Fluharty AL Attenuated activities and structural alterations of arylsulfatase A in tissues from subjects with pseudo arylsulfatase A deficiency. Hum. Genet. 1986, 74:59-62.
125. Kitano A, Nishiyama S, Miike T, Hattori S, Ohtani Y, Matsuda I Mitochondrial cytopathy with lactic acidosis, carnitine deficiency and DeToni-Fanconi-Debre syndrome. Brain Dev. 1986, 8:289-295.
126. Knochel JP Mechanisms of rhabdomyolysis. Curr. Opin. Rheumatol. 1993, 5:725-731.
127. Kobayashi T, Muto S, Nemoto J, et al. Fanconi's syndrome and distal (type 1) renal tubular acidosis in a patient with primary Sjogren's syndrome with monoclonal gammopathy of undetermined significance. Clin. Nephrol. 2006, 65:427-432.
128. Kondo R, Wakamatsu N, Yoshino H, Fukuhara N, Miyatake T, Tsuji S Identification of a mutation in the arylsulfatase A gene of a patient with adult-type metachromatic leukodystrophy. Am. J. Hum. Genet. 1991, 48:971-978.
129. Koobs DH Phosphate mediation of the Crabtree and Pasteur effects. Science 1972, 178:127-133.
130. Kozyraki R, Fyfe J, Verroust PJ, et al. Megalin-dependent cubilinmediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia. Proc. Natl Acad. Sci. USA 2001, 98:12491-12496.
131. Kramer HJ, Gonick HC Experimental Fanconi syndrome. I. Effect of maleic acid on renal cortical Na-K-ATPase activity and ATP levels. J. Lab. Clin. Med. 1970, 76:799-808.
132. Kramer HJ, Gonick HC Effect of maleic acid on sodium-linked tubular transport in experimental Fanconi syndrome. Nephron 1973, 10:306-319.
133. Kramer HJ, Gonick HC, Lu E In vitro inhibition of Na-K-ATPase by trace metals: relation to renal and cardiovascular damage. Nephron 1986, 44:329-336.
134. Kuwertz-Broking E, Koch HG, Marquardt T, et al. Renal Fanconi syndrome: first sign of partial respiratory chain complex IV deficiency. Pediatr. Nephrol. 2000, 14:495-498.
135. Laine J, Salo MK, Krogerus L, Karkkainen J, Wahlroos O, Holmberg C The nephropathy of type I tyrosinemia after liver transplantation. Pediatr. Res. 1995, 37:640-645.
136. Lande MB, Kim MS, Bartlett C, Guay-Woodford LM Reversible Fanconi syndrome associated with valproate therapy. J. Pediatr. 1993, 23:320-322.
137. LaNoue KF, Schoolwerth AC Metabolite transport in mitochondria. Annu. Rev. Biochem. 1979, 48:871-922.
138. Larochelle J, Mortezai A, Belanger M, Tremblay M, Claveau JC, Aubin G Experience with 37 infants with tyrosinemia. Can. Med. Assoc. J. 1967, 97:1051-1054.
139. Lassiter WE, Colindres RE Phosphate reabsorption in the distal convoluted tubule. Adv. Exp. Med. Biol. 1982, 151:21-32.
140. Lee S, Lee T, Lee B, et al. Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid. Nephrology (Carlton) 2004, 9:126-129.
141. Leheste JR, Rolinski B, Vorum H, et al. Megalin knockout mice as an animal model of low molecular weight proteinuria. Am. J. Pathol. 1999, 155:1361-1370.
142. Lei KJ, Shelly LL, Pan CJ, Sidbury JB, Chou JY Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science 1993, 262:580-583.
143. Lenoir GR, Perignon JL, Gubler MC, Broyer M Valproic acid: a possible cause of proximal tubular renal syndrome. J. Pediatr. 1981, 98:503-504.
144. Leonard JV, Hyland K, Furukawa N, Clayton PT Mitochondrial phosphoenolpyruvate carboxykinase deficiency. Eur. J. Pediatr. 1991, 150:198-199.
145. Leslie ND Insights into the pathogenesis of galactosemia. Annu. Rev. Nutr. 2003, 23:59-80.
146. Leu ML, Strickland GT, Gutman RA Renal function in Wilson's disease: response to penicillamine therapy. Am. J. Med. Sci. 1970, 260:381-398.
147. Lian LM, Chang YC, Yang CC, Yang JC, Kao KP, Chung MY Adult Fanconi syndrome with proximal muscle weakness and hypophosphatemic osteomalacia: report of a case. J. Formos. Med. Assoc. 1994, 93:709-714.
148. Lignac GO Über störing des cystinstoffwechsels bei kindern. Deutsches Archiv für Klinische Medizin 1924, 145:139-150.
149. Lin T, Orrison BM, Leahey AM, et al. Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome. Am. J. Hum. Genet. 1997, 60:1384-1388.
150. Liu FY, Cogan MG Axial heterogeneity in the rat proximal convoluted tubule. I. Bicarbonate, chloride, and water transport. Am. J. Physiol. 1984, 247:F816-F821.
151. Lloyd SE, Gunther W, Pearce SH, et al. Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders. Hum. Mol. Genet. 1997, 6:1233-1239.
152. Lloyd SE, Pearce SH, Fisher SE, et al. A common molecular basis for three inherited kidney stone diseases. Nature 1996, 379:445-449.
153. Lowe CU, Terrey M, MacLachlan EA Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity. AMA Am. J. Dis. Child. 1952, 83:164-184.
154. Luijerink MC, van Beurden EA, Malingre HE, et al. Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1. Kidney Int. 2004, 66:990-1000.
155. Madsen PP, Kibaek M, Roca X, et al. Short/branched-chain acyl-CoA dehydrogenase deficiency due to an IVS3+3A>G mutation that causes exon skipping. Hum. Genet. 2006, 118:680-690.
156. Maesaka JK, McCaffery M Evidence for renal tubular leakage in maleic acid-induced Fanconi syndrome. Am. J. Physiol. 1980, 239:F507-F513.
157. Malakauskas SM, Quan H, Fields TA, et al. Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin. Am. J. Physiol. Renal Physiol. 2006.
158. Mandel LJ Metabolic substrates, cellular energy production, and the regulation of proximal tubular transport. Annu. Rev. Physiol. 1985, 47:85-101.
159. Manz F, Bickel H, Brodehl J, et al. Fanconi-Bickel syndrome. Pediatr. Nephrol. 1987, 1:509-518.
160. Markello TC, Bernardini IM, Gahl WA Improved renal function in children with cystinosis treated with cysteamine. N. Engl. J. Med. 1993, 328:1157-1162.
161. Marshansky V, Ausiello DA, Brown D Physiological importance of endosomal acidification: potential role in proximal tubulopathies. Curr. Opin. Nephrol. Hypertens. 2002, 11:527-537.
162. Matsubara Y, Narisawa K, Miyabayashi S, Tada K, Coates PM Molecular lesion in patients with medium-chain acyl-CoA dehydrogenase deficiency. Lancet 1990, 335:1589.
163. McCune DJ Intractable hypophosphatemic rickets with renal glycosuria and acidosis (the Fanconi syndrome). Am. J. Dis. Child. 1943, 65:81.
164. McGivan JD, Klingenberg M Correlation between H+ and anion movement in mitochondria and the key role of the phosphate carrier. Eur. J. Biochem. 1971, 20:392-399.
165. Meijer AJ, Van Dam K The metabolic significance of anion transport in mitochondria. Biochim. Biophys. Acta 1974, 346:213-244.
166. Moe OW, Baum M, Berry CA, Rector FC Renal Transport of Glucose, Amino Acids, Sodium, Chloride and Water. The Kidney 2004, 413-452. Saunders, Philadelphia, PA. B.M. Brenner (Ed.).
167. Montoliu J, Carrera M, Darnell A, Revert L Lactic acidosis and Fanconi's syndrome due to degraded tetracycline. Br. Med. J. (Clin. Res. Ed.) 1981, 283:1576-1577.
168. Morales FC, Takahashi Y, Kreimann EL, Georgescu MM Ezrinradixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia. Proc. Natl Acad. Sci. USA 2004, 101:17705-17710.
169. Morgan HG, Stewart WK, Lowe KG, Stowers JM, Johnstone JH Wilson's disease and the Fanconi syndrome. Q. J. Med. 1962, 31:361-384.
170. Mori K, Narahara K, Ninomiya S, Goto Y, Nonaka I Renal and skin involvement in a patient with complete Kearns-Sayre syndrome. Am. J. Med. Genet. 1991, 38:583-587.
171. Morris AA, Olpin SE, Van't Hoff WG, Johnson AW, Leonard JV Renal tubular dysfunction in multiple acyl-CoA dehydrogenase deficiency. J. Inherit. Metab. Dis. 1997, 20:604-605.
172. Morris AA, Taylor RW, Birch-Machin MA, et al. Neonatal Fanconi syndrome due to deficiency of complex III of the respiratory chain. Pediatr. Nephrol. 1995, 9:407-411.
173. Morris RC An experimental renal acidification defect in patients with hereditary fructose intolerance. I. Its resemblance to renal tubular acidosis. J. Clin. Invest. 1968, 47:1389-1398.
174. Morris RC An experimental renal acidification defect in patients with hereditary fructose intolerance. II. Its distinction from classic renal tubular acidosis; its resemblance to the renal acidification defect associated with the Fanconi syndrome of children with cystinosis. J. Clin. Invest. 1968, 47:1648-1663.
175. Morris RC, McSherry E, Sebastian A Modulation of experimental renal dysfunction of hereditary fructose intolerance by circulating parathyroid hormone. Proc. Natl Acad. Sci. USA 1971, 68:132-135.
176. Morris RC, Nigon K, Reed EB Evidence that the severity of depletion of inorganic phosphate determines the severity of the disturbance of adenine nucleotide metabolism in the liver and renal cortex of the fructose-loaded rat. J. Clin. Invest. 1978, 61:209-220.
177. Moser HW Sulfatide lipidosis: metachromatic leukodystrophy. The Metabolic Basis of Inherited Disease 1972, 688-729. McGraw-Hill, New York. J.B. Stanbury, J.B. Wyngaarden, D.S. Fredrickson (Eds.).
178. Mujais SK Maleic acid-induced proximal tubulopathy: Na:K pump inhibition. J. Am. Soc. Nephrol. 1993, 4:142-147.
179. Nissim I, Weinberg JM Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats. Kidney Int. 1996, 49:684-695.
180. Noonan CH, Kay JM Prevalence and geographic distribution of Fanconi syndrome in Basenjis in the United States. J. Am. Vet. Med. Assoc. 1990, 197:345-349.
181. Norden AG, Lapsley M, Igarashi T, et al. Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome. J. Am. Soc. Nephrol. 2002, 13:125-133.
182. Nussbaum RL, Orrison BM, Janne PA, Charnas L, Chinault AC Physical mapping and genomic structure of the Lowe syndrome gene OCRL1. Hum. Genet. 1997, 99:145-150.
183. Nykjaer A, Fyfe JC, Kozyraki R, et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc. Natl Acad. Sci. USA 2001, 98:13895-13900.
184. Ogier H, Lombes A, Scholte HR, et al. de Toni-Fanconi-Debre syndrome with Leigh syndrome revealing severe muscle cytochrome c oxidase deficiency. J. Pediatr. 1988, 112:734-739.
185. Orfila C, Lepert JC, Modesto A, Bernadet P, Suc JM Fanconi's syndrome, kappa light-chain myeloma, non-amyloid fibrils and cytoplasmic crystals in renal tubular epithelium. Am. J. Nephrol. 1991, 11:345-349.
186. Orita Y, Fukuhara Y, Yanase M, et al. The mechanism of decreased Na+dependent D-glucose transport in brush-border membrane vesicles from rabbit kidneys with experimental Fanconi syndrome. Biochim. Biophys. Acta 1984, 771:195-200.
187. Parsonage MJ, Wilkins EG, Snowden N, Issa BG, Savage MW The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. HIV Med. 2005, 6:341-346.
188. Petrukhin K, Lutsenko S, Chernov I, Ross BM, Kaplan JH, Gilliam TC Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum. Mol. Genet. 1994, 3:1647-1656.
189. Pfister MF, Ruf I, Stange G, Ziegler U, Lederer E, Biber J, Murer H Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter. Proc. Natl Acad. Sci. USA 1998, 95:1909-1914.
190. Pham T, Furno-Steib S, Daumen-Legre V, Acquaviva PC, Lafforgue P Bilateral symmetric polyarthralgia revealing Fanconi's syndrome. Joint Bone Spine 2002, 69:209-213.
191. Phaneuf D, Labelle Y, Berube D, Arden K, Cavenee W, Gagne R, Tanguay RM Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome 15. Am. J. Hum. Genet. 1991, 48:525-535.
192. Piwon N, Gunther W, Schwake M, Bosl MR, Jentsch TJ ClC-5 Cl- channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 2000, 408:369-373.
193. Pontoglio M, Barra J, Hadchouel M, et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 1996, 84:575-585.
194. Pontoglio M, Prie D, Cheret C, et al. HNF1alpha controls renal glucose reabsorption in mouse and man. EMBO Rep. 2000, 1:359-365.
195. Pontoglio M, Sreenan S, Roe M, et al. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J. Clin. Invest. 1998, 101:2215-2222.
196. Pook MA, Wrong O, Wooding C, Norden AG, Feest TG, Thakker RV Dent's disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to Xp11.22. Hum. Mol. Genet. 1993, 2:2129-2134.
197. Poole-Wilson PA, Cameron IR Intracellular pH and K+ of cardiac and skeletal muscle in acidosis and alkalosis. Am. J. Physiol. 1975, 229:1305-1310.
198. Preisig PA, Ives HE, Cragoe EJ, Alpern RJ, Rector FC Role of the Na+/H+ antiporter in rat proximal tubule bicarbonate absorption. J. Clin. Invest. 1987, 80:970-978.
199. Preisig PA, Rector FC Role of Na+-H+ antiport in rat proximal tubule NaCl absorption. Am. J. Physiol. 1988, 255:F461-F465.
200. Rago RP, Miles JM, Sufit RL, Spriggs DR, Wilding G Suramin-induced weakness from hypophosphatemia and mitochondrial myopathy. Association of suramin with mitochondrial toxicity in humans. Cancer 1994, 73:1954-1959.
201. Rampini S, Fanconi A, Illig R, Prader A Effect of hydrochlorothiazide on proximal renal tubular acidosis in a patient with idiopathic "de tonidebre-fanconi syndrome". Helv. Paediatr. Acta 1968, 23:13-21.
202. Rector FC Sodium, bicarbonate, and chloride absorption by the proximal tubule. Am. J. Physiol. 1983, 244:F461-F471.
203. Reczek D, Berryman M, Bretscher A Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrinradixin-moesin family. J. Cell. Biol. 1997, 139:169-179.
204. Reichardt JK, Belmont JW, Levy HL, Woo SL Characterization of two missense mutations in human galactose-1-phosphate uridyltransferase: different molecular mechanisms for galactosemia. Genomics 1992, 12:596-600.
205. Reichardt JK, Berg P Cloning and characterization of a cDNA encoding human galactose-1-phosphate uridyl transferase. Mol. Biol. Med. 1988, 5:107-122.
206. Reitsma-Bierens WC Renal complications in glycogen storage disease type I. Eur. J. Pediatr. 1993, 152(Suppl 1):S60-S62.
207. Reynolds R, McNamara PD, Segal S On the maleic acid induced Fanconi syndrome: effects on transport by isolated rat kidney brushborder membrane vesicles. Life Sci. 1978, 22:39-43.
208. Rogulski J, Pacanis A, Strzelecki T, Kaminska E, Angielski S Effects of maleate on carbohydrate metabolism in rats. Am. J. Physiol. 1976, 230:1163-1167.
209. Rogulski J, Strzelecki T, Pacanis A, Kaminska E, Angielski S Effects of maleate on renal carbohydrate metabolism in vivo and in vitro. Curr. Probl. Clin. Biochem. 1975, 4:106-110.
210. Ronco P, Aucouturier P, Mougenot B Plasma cell dyscrasia-related glomerulopathies and Fanconi's syndrome: a molecular approach. J. Nephrol. 2000, 13(Suppl 3):S34-S44.
211. Rosen VJ, Kramer HJ, Gonick HC Experimental Fanconi syndrome. II. Effect of maleic acid on renal tubular ultrastructure. Lab. Invest. 1973, 28:446-455.
212. Rossi R Nephrotoxicity of ifosfamide - moving towards understanding the molecular mechanisms. Nephrol. Dial. Transplant. 1997, 12:1091-1092.
213. Rossi R, Pleyer J, Schafers P, et al. Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients. Med. Pediatr. Oncol. 1999, 32:177-182.
214. Roth KS, Medow MS, Moses LC, Spencer PD, Schwarz SM Renal Fanconi syndrome: developmental basis for a new animal model with relevance to human disease. Biochim. Biophys. Acta 1989, 987:38-46.
215. Russo P, O'Regan S Visceral pathology of hereditary tyrosinemia type I. Am. J. Hum. Genet. 1990, 47:317-324.
216. Sabolic I, Haase W, Burckhardt G ATP-dependent H+ pump in membrane vesicles from rat kidney cortex. Am. J. Physiol. 1985, 248:F835-F844.
217. Sabolic I, Herak-Kramberger CM, Antolovic R, Breton S, Brown D Loss of basolateral invaginations in proximal tubules of cadmium-intoxicated rats is independent of microtubules and clathrin. Toxicology 2006, 218:149-163.
218. Sabolic I, Ljubojevic M, Herak-Kramberger CM, Brown D Cd-MT causes endocytosis of brush-border transporters in rat renal proximal tubules Am. J. Physiol. Renal Physiol. 2002, 283:F1389-F1402.
219. Saito T, Furyama T, Onodera S, Saito H, Shioji R Renal impairment in patients with paroxysmal nocturnal hemoglobinuria. Tohoku J. Exp. Med. 1975, 116:267-275.
220. Sakamoto O, Ogawa E, Ohura T, et al. Mutation analysis of the GLUT2 gene in patients with Fanconi-Bickel syndrome. Pediatr. Res. 2000, 48:586-589.
221. Sakarcan A, Aricheta R, Baum M Intracellular cystine loading causes proximal tubule respiratory dysfunction: effect of glycine. Pediatr. Res. 1992, 32:710-713.
222. Sakarcan A, Timmons C, Baum M Intracellular distribution of cystine in cystine-loaded proximal tubules. Pediatr. Res. 1994, 35:447-450.
223. Salmon RF, Baum M Intracellular cystine loading inhibits transport in the rabbit proximal convoluted tubule. J. Clin. Invest. 1990, 85:340-344.
224. Santer R, Groth S, Kinner M, et al. The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome. Hum. Genet. 2002, 110:21-29.
225. Santer R, Schneppenheim R, Dombrowski A, Gotze H, Steinmann B, Schaub J Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat. Genet. 1997, 17:324-326.
226. Santer R, Schneppenheim R, Dombrowski A, Gotze H, Steinmann B, Schaub J Fanconi-Bickel syndrome - a congenital defect of the liver-type facilitative glucose transporter. SSIEM Award. Society for the Study of Inborn Errors of Metabolism. J. Inherit. Metab. Dis. 1998, 21:191-194.
227. Santer R, Schneppenheim R, Suter D, Schaub J, Steinmann B Fanconi-Bickel syndrome - the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Eur. J. Pediatr. 1998, 157:783-797.
228. Scharer K, Yoshida T, Voyer L, Berlow S, Pietra G, Metcoff J Impaired renal gluconeogenesis and energy metabolism in maleic acid-induced nephropathy in rats. Res. Exp. Med. (Berl.) 1972, 157:136-152.
229. Scheinman SJ X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int. 1998, 53:3-17.
230. Scheinman SJ, Guay-Woodford LM, Thakker RV, Warnock DG Genetic disorders of renal electrolyte transport. N. Engl. J. Med. 1999, 340:1177-1187.
231. Schonheyder F, Gregersen G, Hansen HE, Skov PE Renal clearances of different amino acids in Wilson's disease before and after treatment with penicillamine. Acta Med. Scand. 1971, 190:395-399.
232. Sebastian A, McSherry E, Morris RC On the mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA). J. Clin. Invest. 1971, 50:231-243.
233. Sebastian A, McSherry E, Morris RC Renal potassium wasting in renal tubular acidosis (RTA): its occurrence in types 1 and 2 RTA despite sustained correction of systemic acidosis. J. Clin. Invest. 1971, 50:667-678.
234. Settles EL, Schmidt D Fanconi syndrome in a Labrador retriever. J. Vet. Intern. Med. 1994, 8:390-393.
235. Shah M, Quigley R, Baum M Neonatal rabbit proximal tubule basolateral membrane Na+/H+ antiporter and Cl-/base exchange. Am. J. Physiol. 1999, 276:R1792-R1797.
236. Shapiro LJ, Aleck KA, Kaback MM, et al. Metachromatic leukodystrophy without arylsulfatase A deficiency. Pediatr. Res. 1979, 13:1179-1181.
237. Shenolikar S, Voltz JW, Minkoff CM, Wade JB, Weinman EJ Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. Proc. Natl Acad. Sci. USA 2002, 99:11470-11475.
238. Shvil Y, Wald H, Popovtzer MM Effect of bicarbonate and phosphate on renal phosphate leak in experimental Fanconi syndrome. Am. J. Physiol. 1987, 252:F310-F316.
239. Silverman M The mechanism of maleic acid nephropathy: investigations using brush border membrane vesicles. Membr. Biochem. 1981, 4:63-69.
240. Sirac C, Bridoux F, Carrion C, et al. Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome. Blood 2006, 108:536-543.
241. Skinner R Chronic ifosfamide nephrotoxicity in children. Med. Pediatr. Oncol. 2003, 41:190-197.
242. Sliman GA, Winters WD, Shaw DW, Avner ED Hypercalciuria and nephrocalcinosis in the oculocerebrorenal syndrome. J. Urol. 1995, 153:1244-1246.
243. Spencer PD, Medow MS, Moses LC, Roth KS Effects of succinylacetone on the uptake of sugars and amino acids by brush border vesicles. Kidney Int. 1988, 34:671-677.
244. Springate JE, Van Liew JB Nephrotoxicity of ifosfamide in rats. J. Appl. Toxicol. 1995, 15:399-402.
245. Stevens RL, Fluharty AL, Kihara H, et al. Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy. Am. J. Hum. Genet. 1981, 33:900-906.
246. Suchy SF, Nussbaum RL The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization. Am. J. Hum. Genet. 2002, 71:1420-1427.
247. Sun MS, Hattori S, Kubo S, Awata H, Matsuda I, Endo F A mouse model of renal tubular injury of tyrosinemia type 1: development of de Toni Fanconi syndrome and apoptosis of renal tubular cells in Fah/Hpd double mutant mice. J. Am. Soc. Nephrol. 2000, 11:291-300.
248. Sussman I, Erecinska M, Wilson DF Regulation of cellular energy metabolism: the Crabtree effect. Biochim. Biophys. Acta 1980, 591:209-223.
249. Szabolcs MJ, Seigle R, Shanske S, Bonilla E, DiMauro S, D'Agati V Mitochondrial DNA deletion: a cause of chronic tubulointerstitial nephropathy. Kidney Int. 1994, 45:1388-1396.
250. Tabatabai NM, Blumenthal SS, Lewand DL, Petering DH Differential regulation of mouse kidney sodium-dependent transporters mRNA by cadmium. Toxicol. Appl. Pharmacol. 2001, 177:163-173.
251. Tabatabai NM, Blumenthal SS, Lewand DL, Petering DH Mouse kidney expresses mRNA of four highly related sodium-glucose cotransporters: regulation by cadmium. Kidney Int. 2003, 64:1320-1330.
252. Tabatabai NM, Blumenthal SS, Petering DH Adverse effect of cadmium on binding of transcription factor Sp1 to the GC-rich regions of the mouse sodium-glucose cotransporter 1, SGLT1, promoter. Toxicology 2005, 207:369-382.
253. Tabei K, Muto S, Furuya H, Sakairi Y, Ando Y, Asano Y Potassium secretion is inhibited by metabolic acidosis in rabbit cortical collecting ducts in vitro. Am. J. Physiol. 1995, 268:F490-F495.
254. Tabet M De Toni-Debre-Fanconi syndrome in Wilson's disease. J. Med. Liban. 1969, 22:55-65.
255. Tanaka A, Nishida R, Maeda K, Sugawara A, Kuwahara T Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy?. Clin. Nephrol. 2000, 53:301-306.
256. Theodoropoulos DS, Shawker TH, Heinrichs C, Gahl WA Medullary nephrocalcinosis in nephropathic cystinosis. Pediatr. Nephrol. 1995, 9:412-418.
257. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW The Wilson disease gene: spectrum of mutations and their consequences. Nat. Genet. 1995, 9:210-217.
258. Thorner PS, Bedard YC, Fernandes BJ Lambda-light-chain nephropathy with Fanconi's syndrome. Arch. Pathol. Lab. Med. 1983, 107:654-657.
259. Tolan DR, Penhoet EE Characterization of the human aldolase B gene. Mol. Biol. Med. 1986, 3:245-264.
260. Town M, Jean G, Cherqui S, et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat. Genet. 1998, 18:319-324.
261. Trevisan A, Gardin C Nephrolithiasis in a worker with cadmium exposure in the past. Int. Arch. Occup. Environ. Health 2005, 78:670-672.
262. Truong LD, Mawad J, Cagle P, Mattioli C Cytoplasmic crystals in multiple myeloma-associated Fanconi's syndrome. A morphological study including immunoelectron microscopy. Arch. Pathol. Lab. Med. 1989, 113:781-785.
263. Tsai CS, Chen YC, Chen HH, Cheng CJ, Lin SH An unusual cause of hypokalemic paralysis: aristolochic acid nephropathy with Fanconi syndrome. Am. J. Med. Sci. 2005, 330:153-155.
264. Usberti M, Pecoraro C, Federico S, et al. Mechanism of action of indomethacin in tubular defects. Pediatrics 1985, 75:501-507.
265. Van Furden D, Johnson K, Segbert C, Bossinger O The C. elegans ezrin-radixin-moesin protein ERM-1 is necessary for apical junction remodelling and tubulogenesis in the intestine. Dev. Biol. 2004, 272:262-276.
266. Wang LC, Lee WT, Tsai WY, Tsau YK, Shen YZ Mitochondrial cytopathy combined with Fanconi's syndrome. Pediatr. Neurol. 2000, 22:403-406.
267. Wang SS, Devuyst O, Courtoy PJ, et al. Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum. Mol. Genet. 2000, 9:2937-2945.
268. Wang Y, Cai H, Cebotaru L, et al. ClC-5: role in endocytosis in the proximal tubule. Am. J. Physiol. Renal Physiol. 2005, 289:F850-F862.
269. Watanabe T, Yoshikawa H, Yamazaki S, Abe Y, Abe T Secondary renal Fanconi syndrome caused by valproate therapy. Pediatr. Nephrol. 2005, 20:814-817.
270. Wiebers DO, Wilson DM, McLeod RA, Goldstein NP Renal stones in Wilson's disease. Am. J. Med. 1979, 67:249-254.
271. Wong D Hereditary fructose intolerance. Mol. Genet. Metab. 2005, 85:165-167.
272. Woodland C, Ito S, Granvil CP, Wainer IW, Klein J, Koren G Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites. Life Sci. 2000, 68:109-117.
273. Wyss PA, Boynton SB, Chu J, Spencer RF, Roth KS Physiological basis for an animal model of the renal Fanconi syndrome: use of succinylacetone in the rat. Clin. Sci. (Lond) 1992, 83:81-87.
274. Yagame M, Tomino Y, Miura M, Suga T, Nomoto Y, Sakai H An adult case of Fanconi's syndrome associated with membranous nephropathy. Tokai. J. Exp. Clin. Med. 1986, 11:101-106.
275. Yamagata K, Oda N, Kaisaki PJ, et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996, 384:455-458.
276. Yanase M, Orita Y, Okada N, et al. Decreased Na+-gradient-dependent D-glucose transport in brush-border membrane vesicles from rabbits with experimental Fanconi syndrome. Biochim. Biophys. Acta 1983, 733:95-101.
277. Yang SS, Chu P, Lin YF, Chen A, Lin SH Aristolochic acid-induced Fanconi's syndrome and nephropathy presenting as hypokalemic paralysis. Am. J. Kidney Dis. 2002, 39:E14.
278. Yang YS, Peng CH, Sia SK, Huang CN Acquired hypo-phosphatemia osteomalacia associated with Fanconi's syndrome in Sjogren's syndrome. Rheumatol Int. 2006.
279. Yearley JH, Hancock DD, Mealey KL Survival time, lifespan, and quality of life in dogs with idiopathic Fanconi syndrome. J. Am. Vet. Med. Assoc. 2004, 225:377-383.
280. Yonemura S, Tsukita S, Tsukita S Direct involvement of ezrin/radixin/moesin (ERM)-binding membrane proteins in the organization of microvilli in collaboration with activated ERM proteins. J. Cell. Biol. 1999, 145:1497-1509.
281. Zeviani M, Nonaka I, Bonilla E, et al. Fatal infantile mitochondrial myopathy and renal dysfunction caused by cytochrome c oxidase deficiency: immunological studies in a new patient. Ann. Neurol. 1985, 17:414-417.